Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma

被引：0
|
作者：
Semra Paydas
Ali Ogul
Cem Irili
Serkan Gokcay
机构：
[1] Cukurova University Faculty of Medicine,Department of Medical Oncology
来源：
Annals of Hematology | 2016年 / 95卷
关键词：
Neuropathy; Peripheral Neuropathy; Dose Adjustment; Hodgkin Lymphoma; Bendamustine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：145 / 146
页数：1
相关论文
共 50 条
  • [1] Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma
    Paydas, Semra
    Ogul, Ali
    Irili, Cem
    Gokcay, Serkan
    ANNALS OF HEMATOLOGY, 2016, 95 (01) : 145 - 146
  • [2] Correction to: Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma
    Semra Paydas
    Ali Ogul
    Cem Mirili
    Serkan Gokcay
    Annals of Hematology, 2019, 98 : 1803 - 1803
  • [3] Brentuximab vedotin use in a jaundiced case with resistant Hodgkin lymphoma (vol 95, pg 145, 2016)
    Paydas, Semra
    Ogul, Ali
    Mirili, Cem
    Gokcay, Serkan
    ANNALS OF HEMATOLOGY, 2019, 98 (07) : 1803 - 1803
  • [4] BRENTUXIMAB VEDOTIN IS EFFECTIVE IN HODGKIN LYMPHOMA
    不详
    CANCER DISCOVERY, 2012, 2 (05) : 385 - 385
  • [5] Brentuximab vedotin in Hodgkin's lymphoma
    Pro, Barbara
    Perini, Guilherme Fleury
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2012, 12 (10) : 1415 - 1421
  • [6] Brentuximab vedotin and transplantation in Hodgkin Lymphoma
    Castagna, Luca
    Sarina, Barbara
    Bramanti, Stefania
    Calabretta, Eleonora
    Mariotti, Jacopo
    Morabito, Lucio
    DRUGS AND CELL THERAPIES IN HEMATOLOGY, 2015, 3 (04): : 218 - 225
  • [7] Brentuximab Vedotin in Advanced Hodgkin's Lymphoma
    Haslam, Alyson
    Prasad, Vinay
    NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (16): : 1527 - 1527
  • [8] Brentuximab Vedotin in Children with Hodgkin's Lymphoma
    Kazantsev, I.
    Kozlov, A.
    Iukhta, T.
    Gevorgian, A.
    Tolkunova, P.
    Tsvetkova, L.
    Morozova, E.
    Lepik, K.
    Kulagin, A.
    Mikhailova, N.
    Zubarovskaya, L.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S202 - S202
  • [9] Desensitization of Brentuximab Vedotin in a Patient with Hodgkin Lymphoma
    Khalid, Sidra
    Khalid, Aariez
    Clark, Bernadette A.
    Daw, Hamed
    CUREUS, 2018, 10 (07):
  • [10] Brentuximab vedotin for the treatment of Hodgkin's lymphoma
    Anh Pham
    Chen, Robert
    EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (04) : 403 - 412
12345